DENOVO BIOLABS PVT. LTD.’s Post

In this new eBook, AGC Biologics' Naveenganesh Muralidharan and team explore critical aspects of biopharmaceutical manufacturing, including mass transfer, CO2 control, shear assessment, process validation, statistical methods for process optimization, and much more. This resource offers solutions to some of the top challenges and questions in biologics cell culture manufacturing, and we're giving it to you for free.  Grab your copy by accessing the link in the comments below. #AGCBio #CDMO #biotech #pharmaceuticals #LifeScience #Biotechnology #Biopharmaceuticals

🔬 Don't Miss Out on Our Exclusive On-Demand Webinar! 🔬 In this insightful webinar, our panel of Experts will unravel key considerations and best practices to guide you in selecting the perfect bioreactor controls platform for your biopharmaceutical endeavors. ✔ Discover the crucial factors to consider when choosing your bioreactor controls platform. ✔ Learn how to support a platform that seamlessly scales up from lab to pilot to manufacturing, accommodating your evolving needs and growth. ✔ Explore strategies for future-proofing your bioreactor control platforms. ✔ Gain insights into the range of Catalyx bioreactor control platforms available to support different processes. Don't miss this opportunity to expand your knowledge and optimize your bioprocessing endeavors! 💡🚀 https://lnkd.in/enA7EZE8 #BioreactorControls #CellCulture #Biopharmaceuticals #CatalyxWebinar #Innovation #BioprocessingExcellence

What are the challenges, technological innovation needs, and major trends currently present in the biopharmaceutical and biotechnology industries? I wrote a blog that discusses the recent technological advancements within the future-driven biopharma sector and highlights Timegate's continuous efforts to cater to the industry by consistently refining our offerings to meet the evolving needs of our customers. The blog also provides an overview of Timegate's performance in 2023 and emphasizes our commitment to growth and innovation in the upcoming year of 2024. Have a read and feel free to contact me if you have any thoughts! #timegating #processmonitoring #biopharma #biotechnology #development

🌟 Exciting News Alert! 🌟 Dive into the dynamic world of biopharmaceuticals with the Protein A Resins Market! 💡 Discover how these innovative resins are revolutionizing purification processes, ensuring the highest quality monoclonal antibodies for therapeutic use. 🧬 From enhancing production efficiency to meeting stringent regulatory standards, Protein A resins are powering the future of biotech. 💪 Join the conversation and unlock the potential of biopharmaceutical manufacturing! #ProteinAResins #BiotechInnovation #BioPharma 🚀🔬 Get more details @ https://lnkd.in/d8kw-BBu

As biopharmaceutical companies pioneer new molecules and treatments, it is evident that the stability of these molecules is becoming a detrimental factor with every iteration and that lyophilization is the pathway to a solution.   At PCI Pharma Services, we believe lyophilization cycle development is not only a science but an art. Each drug product that comes into our laboratories presents unique challenges, and the design of a cycle requires an understanding of individual chemistry, characteristics, and interactions to yield a high-quality product.   Read our latest case study to learn how we partnered with a small US-based biotech client to develop a strategic three-part lyophilization cycle development plan for their labile monoclonal antibody to address not only their short-term objective of advancing the product into the clinic but also to plan for the later stage clinical trial program and ultimately commercialization.   https://lnkd.in/gsR8MKHR   #Lyophilization #Biotech #CDMO   #LetsTalkFuture

The Unseen Challenges in Biopharmaceutical Development Biopharma development is often portrayed as a series of groundbreaking discoveries. But behind every successful biosimilar, monoclonal antibody, or recombinant protein lies a labyrinth of challenges—technical, regulatory, and operational. In my experience, analytical characterization often emerges as one of the most intricate hurdles. From ensuring product quality to meeting stringent regulatory expectations, every step demands precision, collaboration, and innovation. For instance, aligning critical quality attributes (CQAs) from upstream processes like cell line development to downstream purification can feel like solving a massive jigsaw puzzle—one where every piece impacts patient safety. How do you or your teams tackle these challenges? Are there any specific hurdles that keep you up at night—whether in upstream processes, analytics, or regulatory submissions? Let’s discuss the hidden battles that make biopharma innovation possible. Your insights could spark the next wave of solutions. #Biosimilars #Biopharma #Innovation #Collaboration Zelle Research & Analytical Services

Advancing Your Molecules to Market with AsymBio! Embarking on the journey of bioconjugate development demands a wealth of expertise, technology, and adaptable methodologies. At Asymbio, we seamlessly integrate our proficiency in payload-linker and antibody CMC with our extensive experience in conjugation process development and analytical development. Our ONE total solution for ADC projects is designed to streamline complex processes, alleviate challenges, and propel your biologics towards successful commercialization. By combining our expertise, we are committed to redefining the possibilities within biologics development, offering a seamless and comprehensive approach from inception to manufacturing. Join us in shaping the future of bioconjugate! Let's connect to explore how Asymbio can transform your projects and drive innovation in the biopharmaceutical landscape. More information is available at www.asymbio.com #ADC #Antibody #Payload_Linkers #Development #Manufacturing #Biologics #AsymBio

So Exciting! Johnson & Johnson 's Harsha Gunawardena is teaming up with Protein Metrics, LLC to do a webinar on Novilytic's #Proteometer fueled by #MASC. See https://bit.ly/4eCpPQh to learn how Harsha and his Team utilize this great software and AI to accelerate Biopharmaceutical Characterization and Quantification using MASC !!!

This paper, featuring contributions from several MilliporeSigma experts, aims to standardize the industry's approach to controlling continuous mAb bioprocessing by reducing complexity and barriers to implementation. The goal is to increase access to biopharmaceuticals, reduce time to market, and improve product quality. Download now to learn more!